Individual generic drug information

cefuroxime

Reference monograph

Part of registered formulation

CEFUROXIME

Reference record: Cefuroxime
Source: BNF 80 (2020–2021)
Printed source pages: 1257
Age groups indexed: 1

Individual active ingredientSource records are displayed separately

Some source sections could not be separated reliably in the extraction. Review the printed source pages when a field is missing or incomplete.

Overview

Extracted information for Cefuroxime only.

Indications And Dose

APROKAM ® INTRACAMERAL INJECTION Prophylaxis of endophthalmitis after cataract surgery ▶BY INTRACAMERAL INJECTION ▶Adult: 1 mg, dose to be injected into the anterior chamber of the eye at the end of cataract surgery

Source page 1257

Cautions

APROKAM ® INTRACAMERAL INJECTION ▶With intracameral use Combined operations with cataract surgery. complicated cataracts. reduced corneal endothelial cells (less than 2000). severe risk of infection. severe thyroid disease

Source page 1257

Prescribing And Dispensing Information

For choice of antibacterial therapy, see Eye, infections p. 1234.

Source page 1257

National Funding Access Decisions

APROKAM ® INTRACAMERAL INJECTION Scottish Medicines Consortium (SMC) decisions ▶With intracameral use The Scottish Medicines Consortium has advised (December 2016) that cefuroxime (Aprokam ®) is accepted for use within NHS Scotland for antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery. All Wales Medicines Strategy Group (AWMSG) decisions ▶With intracameral use The All Wales Medicines Strategy Group has advised (August 2017) that cefuroxime (Aprokam ®) is recommended as an option for use within NHS Wales for the antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery.

Source page 1257

Safety

Extracted information for Cefuroxime only.

Interactions

→Appendix 1: cephalosporins

Source page 1257

Pregnancy

Not known to be harmful.

Source page 1257

Breast Feeding

Present in milk in low concentration, but appropriate to use.

Source page 1257

Dose and formulations

Extracted information for Cefuroxime only.

Medicinal Forms

Powder for solution for injection ▶Aprokam (Thea Pharmaceuticals Ltd) Cefuroxime (as Cefuroxime sodium) 50 mg Aprokam 50mg powder for solution for injection vials | 10 vial P £49.95 ANTIBACTERIALS › MACROLIDES eiiii F 565

Source page 1257

Dose text by age group

Filter the extracted dose blocks for this individual drug.

Adults

First line only; read the complete Indications and dose section above.

1 mg, dose to be injected into the anterior

This is a first-line fragment. Read the full Indications and Dose section above.

Candidate age grouping · source page 1257

Age labels are extracted from the printed dose headings and require clinical review. Confirm current local guidance, dose, route, formulation, contraindications and interactions before prescribing.

Individual generic drug information

cefuroxime

Reference monograph

Part of registered formulation

CEFUROXIME

Reference record: Cefuroxime
Source: BNF 80 (2020–2021)
Printed source pages: 1257
Age groups indexed: 1

Individual active ingredientSource records are displayed separately

Some source sections could not be separated reliably in the extraction. Review the printed source pages when a field is missing or incomplete.

Overview

Extracted information for Cefuroxime only.

Indications And Dose

Source page 1257

Cautions

Source page 1257

Prescribing And Dispensing Information

For choice of antibacterial therapy, see Eye, infections p. 1234.

Source page 1257

National Funding Access Decisions

Source page 1257

Safety

Extracted information for Cefuroxime only.

Interactions

→Appendix 1: cephalosporins

Source page 1257

Pregnancy

Not known to be harmful.

Source page 1257

Breast Feeding

Present in milk in low concentration, but appropriate to use.

Source page 1257

Dose and formulations

Extracted information for Cefuroxime only.

Medicinal Forms

Source page 1257

Dose text by age group

Filter the extracted dose blocks for this individual drug.

Adults

First line only; read the complete Indications and dose section above.

1 mg, dose to be injected into the anterior

This is a first-line fragment. Read the full Indications and Dose section above.

Candidate age grouping · source page 1257

Age labels are extracted from the printed dose headings and require clinical review. Confirm current local guidance, dose, route, formulation, contraindications and interactions before prescribing.